Melior Pharmaceuticals identifies and develops new uses for small molecule therapeutics. By applying the proprietary theraTRACE® drug repositioning platform, Melior can rapidly evaluate compounds across multiple therapeutic areas. Once a new indication is identified, Melior will advance the drug through its own internal drug development program or with a strategic partner.

If you are interested in learning more about Melior Pharmaceuticals, please contact bizdev@meliordiscovery.com to start the conversation.